[PDF] Top 20 Novel predictive markers of therapy response in gastric cancer

... conditions. In fact, some researchers have discovered that apoptosis induced by a certain compound can be reversed after removing such compound, leading to cell recovering from a senescent state ...phase of ... See full document

... and predictive biomarkers. In the context of CRC, several such biomarkers have recently been described as poten- tially promising diagnostic biomarkers, including: SEPT9 (Septin 9), a member ... See full document

... adenocarcinoma of the gastro-esophageal junction (GEJ) and stomach were ...series of chemotherapy before surgery, each consisting of a 3-week cycle of intravenous epirubicin, cisplatin or ... See full document

... expression of carbohydrate antigens, several other markers are used in clinical practice such as the case of prostate specific antigen (PSA) and carcinoembryonic antigen ...expressed in ... See full document

... some of them proposed as novel therapeutic targets for several cancer ...remodeler of methylated H3K9, were tightly regulated by HIF-1α under hypoxia conditions ...regulation, in order ... See full document

... part of cancer clinical protocols and is able to furnish morphological,structural, metabolic and functional ...as in vitro tissue and fluids analysis assists in clinical ...and therapy ... See full document

... findings, novel chemotherapeutical agents have been developed and carefully evaluated in clinical trials, with the most commonly used AR-axis-targeted (ARAT) therapies for the treatment of mCRPC ... See full document

... improved response and survival for patients whose tumors express NY-ESO-1 were not the result of increased cytotoxicity, but rather were mediated through immunological ...stimulator of T-Cells and ... See full document

... definition of endocrine-resistance breast cancer is clinical, characterized by a disease behavior (local and/or distal recurrence, progression) that occurs in strictly defined time-periods in ... See full document

... proportion of high stathmin level in metastatic (37%) compared with primary lesions ...ancy in stathmin status was noted in a quarter of paired samples, paralleling findings in ... See full document

... tumor response predictive value [18, 20, 21, ...tumor response to ...effectiveness of both radiation therapy and chemotherapy and are a well-known risk factor for tumor ...number ... See full document

... for gastric cancer, which agrees with the concept that HDAC is overex- pressed in gastric cancer tissues ...acetylation of histones, therefore affecting gene ...stress ... See full document

... ach cancer (27 males and 14 females, me- dian age ...hospitalized in the Department of Surgery, Campinas University Hospital, Campinas, SP, Brazil, during the period from March to November, ...for ... See full document

... mechanism of VEZT’s tumor-inhibiting function, we screened the target genes regulated by ...analysis of experimental samples, such as gene-transfected cells, has led to identification of valuable ... See full document

... overrepresented in non-responder group (p = ...frequent in non-responders than responders: rs2243250 (IL4) A allele (p = ...frequent in non- responders: rs2069762 (IL2) C allele (p = ...use of ... See full document

... frequencies of classical FBC subtypes in male. Luminal tumours in female patients are associated with older age and post- menopausal status [ 48 ...Like in postmenopausal women, there are only ... See full document

... overexpression of Bcl-2 gene can inhibit tumor cell apoptosis induced CCDC134 (Bilim et ...inluence of inhibiting Bcl-2 gene expression on the apoptosis and ...expression of Bcl-2 gene and thus ... See full document

... a predictive factor for pathologic complete response, compare the oncologic outcomes associated with the degree of pathologic response after neoadjuvant chemotherapy, and to analyze pathologic ... See full document

... splicing of a variety of transcripts with tissue-specific expression: The Epithelial Splicing Regulatory Protein 1 and 2 (ESRP1 and ESRP2) [93, ...expression of ESRP1 and ESRP2 was necessary for the ... See full document

... composed of capecitabine plus cisplatin or fluorouracil plus cisplatin administered every 3 weeks for six cycles or chemotherapy in combination with intravenous ...incorporation of trastuzamab to ... See full document